Thrombophlebitis

Approved for this indication (1)

• zinc oxide

Phase 4 trials (3)

• diclofenac
• dalteparin
• diethylamine salicylate

Phase 3 trials (5)

• mucopolysaccharide polysulphate
• warfarin
• enoxaparin
• anacaulase
• trypsin

Phase 1 trials (2)

• heparin
• alteplase

Organization Involved with Phase 4 Indications (6)

• Pfizer
• Novartis
• Ten Sun Pharma Company Limited
• University of Oklahoma
• Taichung Veterans General Hospital
• University of Ljubljana

Organization Involved with Phase 3 Indications (6)

• GlaxoSmithKline
• Mucos Pharma GmbH and Co
• Medinova AG
• National Heart, Lung, and Blood Institute (NHLBI)
• Harvard University
• University of Bologna

Organization Involved with Phase 1 Indications (1)

• National Institutes of Health (NIH)